Physician profile
Arman Erkan
NPI 1114446879
$8,419.01
in general payments reported to CMS, 2019-2025
12 companies · $1,636 in 2025
The $1,636 reported for 2025 was more than what 79% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2021: $128 · 2022: $492 · 2023: $1,155 · 2024: $4,894 · 2025: $1,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,946 · Education: $2,514 · Food and Beverage: $2,217 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,945.59 |
| Education | $2,514.34 |
| Food and Beverage | $2,217.02 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,405.86 | 2024-2025 | |
| Janssen Biotech, INC. | $661.68 | 2022-2025 | Stelara, Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $392.36 | 2021-2023 | Entyvio, Gattex |
| Abbvie INC. | $281.64 | 2022-2023 | |
| Celgene Corporation | $248.28 | 2022-2023 | Zeposia |
| Organon LLC | $124.49 | 2022-2023 | Hadlima, Renflexis |
| Ethicon US, LLC | $113.84 | 2019 | |
| Nestle Healthcare Nutrition INC. | $82.78 | 2021-2022 | |
| Guard Medical INC. | $34.38 | 2024 | Npseal Large |
| Ferring Pharmaceuticals INC. | $33.32 | 2023 | Clenpiq |
| Alcresta Therapeutics, INC. | $24.11 | 2023 | Relizorb |
| Daiichi Sankyo INC. | $16.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arman Erkan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.